Completed PHASE2 INTERVENTIONAL 2-arm NCT01113528

Omega-3 and Aspirin in Periodontal Regeneration (PR)

The Effect of Host Response Modulation Therapy (Omega 3 Plus Low-dose Aspirin) as an Adjunctive Treatment of Chronic Periodontitis (Clinical and Biochemical Study)

Sponsor: Cairo University

Conditions Periodontal Disease

Interventions Regenerative therapy (omega 3 PUFA plus low dose aspirin) Sugar pill

Updated 5 times since 2017 Last updated: May 13, 2010 Started: Nov 30, 2009 Primary completion: Dec 31, 2009 Completion: May 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Periodontal Disease and is currently completed. Cairo University leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Nov 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cairo University
October 6 University

Data source: October 6 University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt